Ro Khanna @RoKhanna
Average insulin costs have almost doubled in four years. Costs keep rising because the three main suppliers abuse the patent system to prevent a generic version from entering the market. We must rein in Big Pharma greed to save lives. https://t.co/vdFAtlPq1i — PolitiTweet.org